PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer

Elaine B. Brunschwig, Keith Wilson, David Mack, Dawn Dawson, Earl Lawrence, James K V Willson, ShiLong Lu, Arman Nosrati, Ronald M. Rerko, Sandra Swinler, Lydia Beard, James D. Lutterbaugh, Joseph Willis, Petra Platzer, Sanford Markowitz

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

To identify potential effectors of transforming growth factor (TGF)-β-mediated suppression of colon cancer, we used GeneChip® expression microarrays to identify TGF-β-induced genes in VACO 330, a nontransformed TGF-β-sensitive cell line derived from a human adenomatous colon polyp. PMEPA1 was identified as a gene highly up-regulated by TGF-β treatment of VACO 330. Northern blot analysis confirmed TGF-β induction of PMEPA1 in VACO 330, as well as a panel of three other TGF-β-sensitive colon cell lines. PMEPA1 induction could be detected as early as 2 h after TGF-β treatment and was not inhibited by pretreatment of cells with cycloheximide, suggesting that PMEPA1 is a direct target of TGF-β signaling. Wild-type PMEPA1 and an alternative splice variant lacking the putative transmembrane domain were encoded by the PMEPA1 locus and were shown by epitope tagging to encode proteins with differing subcellular localization. Both variants were found to be expressed in normal colonic epithelium, and both were shown to be induced by TGF-β. Consistent with TGF-β playing a role in terminal differentiation of colonocytes, in situ hybridization of normal colonic epithelium localized PMEPA1 expression to nonproliferating, terminally differentiated epithelium located at the top of colonic crypts. Intriguingly, in situ hybridization and Northern blot analysis showed that the expression of PMEPA1 was well maintained both in colon cancer primary tumors and in colon cancer liver metastases. PMEPA1 is thus a novel TGF-β-induced marker of a differentiated crypt cell population. Moreover, as PMEPA1 expression is maintained, presumptively in a TGF-β-independent manner after malignant transformation and metastasis, it demonstrates that even late colon cancers retain a strong capacity to execute many steps of the normal colonic differentiation program.

Original languageEnglish (US)
Pages (from-to)1568-1575
Number of pages8
JournalCancer Research
Volume63
Issue number7
StatePublished - Apr 1 2003

Fingerprint

Transforming Growth Factors
Colonic Neoplasms
Epithelium
Northern Blotting
In Situ Hybridization
Colon
Neoplasm Metastasis
Adenomatous Polyps
Cell Line
Cycloheximide
Liver Neoplasms
Genes
Epitopes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Brunschwig, E. B., Wilson, K., Mack, D., Dawson, D., Lawrence, E., Willson, J. K. V., ... Markowitz, S. (2003). PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Research, 63(7), 1568-1575.

PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. / Brunschwig, Elaine B.; Wilson, Keith; Mack, David; Dawson, Dawn; Lawrence, Earl; Willson, James K V; Lu, ShiLong; Nosrati, Arman; Rerko, Ronald M.; Swinler, Sandra; Beard, Lydia; Lutterbaugh, James D.; Willis, Joseph; Platzer, Petra; Markowitz, Sanford.

In: Cancer Research, Vol. 63, No. 7, 01.04.2003, p. 1568-1575.

Research output: Contribution to journalArticle

Brunschwig, EB, Wilson, K, Mack, D, Dawson, D, Lawrence, E, Willson, JKV, Lu, S, Nosrati, A, Rerko, RM, Swinler, S, Beard, L, Lutterbaugh, JD, Willis, J, Platzer, P & Markowitz, S 2003, 'PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer', Cancer Research, vol. 63, no. 7, pp. 1568-1575.
Brunschwig, Elaine B. ; Wilson, Keith ; Mack, David ; Dawson, Dawn ; Lawrence, Earl ; Willson, James K V ; Lu, ShiLong ; Nosrati, Arman ; Rerko, Ronald M. ; Swinler, Sandra ; Beard, Lydia ; Lutterbaugh, James D. ; Willis, Joseph ; Platzer, Petra ; Markowitz, Sanford. / PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. In: Cancer Research. 2003 ; Vol. 63, No. 7. pp. 1568-1575.
@article{0f9783114f354174b0af0a303e39d0ac,
title = "PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer",
abstract = "To identify potential effectors of transforming growth factor (TGF)-β-mediated suppression of colon cancer, we used GeneChip{\circledR} expression microarrays to identify TGF-β-induced genes in VACO 330, a nontransformed TGF-β-sensitive cell line derived from a human adenomatous colon polyp. PMEPA1 was identified as a gene highly up-regulated by TGF-β treatment of VACO 330. Northern blot analysis confirmed TGF-β induction of PMEPA1 in VACO 330, as well as a panel of three other TGF-β-sensitive colon cell lines. PMEPA1 induction could be detected as early as 2 h after TGF-β treatment and was not inhibited by pretreatment of cells with cycloheximide, suggesting that PMEPA1 is a direct target of TGF-β signaling. Wild-type PMEPA1 and an alternative splice variant lacking the putative transmembrane domain were encoded by the PMEPA1 locus and were shown by epitope tagging to encode proteins with differing subcellular localization. Both variants were found to be expressed in normal colonic epithelium, and both were shown to be induced by TGF-β. Consistent with TGF-β playing a role in terminal differentiation of colonocytes, in situ hybridization of normal colonic epithelium localized PMEPA1 expression to nonproliferating, terminally differentiated epithelium located at the top of colonic crypts. Intriguingly, in situ hybridization and Northern blot analysis showed that the expression of PMEPA1 was well maintained both in colon cancer primary tumors and in colon cancer liver metastases. PMEPA1 is thus a novel TGF-β-induced marker of a differentiated crypt cell population. Moreover, as PMEPA1 expression is maintained, presumptively in a TGF-β-independent manner after malignant transformation and metastasis, it demonstrates that even late colon cancers retain a strong capacity to execute many steps of the normal colonic differentiation program.",
author = "Brunschwig, {Elaine B.} and Keith Wilson and David Mack and Dawn Dawson and Earl Lawrence and Willson, {James K V} and ShiLong Lu and Arman Nosrati and Rerko, {Ronald M.} and Sandra Swinler and Lydia Beard and Lutterbaugh, {James D.} and Joseph Willis and Petra Platzer and Sanford Markowitz",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "63",
pages = "1568--1575",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer

AU - Brunschwig, Elaine B.

AU - Wilson, Keith

AU - Mack, David

AU - Dawson, Dawn

AU - Lawrence, Earl

AU - Willson, James K V

AU - Lu, ShiLong

AU - Nosrati, Arman

AU - Rerko, Ronald M.

AU - Swinler, Sandra

AU - Beard, Lydia

AU - Lutterbaugh, James D.

AU - Willis, Joseph

AU - Platzer, Petra

AU - Markowitz, Sanford

PY - 2003/4/1

Y1 - 2003/4/1

N2 - To identify potential effectors of transforming growth factor (TGF)-β-mediated suppression of colon cancer, we used GeneChip® expression microarrays to identify TGF-β-induced genes in VACO 330, a nontransformed TGF-β-sensitive cell line derived from a human adenomatous colon polyp. PMEPA1 was identified as a gene highly up-regulated by TGF-β treatment of VACO 330. Northern blot analysis confirmed TGF-β induction of PMEPA1 in VACO 330, as well as a panel of three other TGF-β-sensitive colon cell lines. PMEPA1 induction could be detected as early as 2 h after TGF-β treatment and was not inhibited by pretreatment of cells with cycloheximide, suggesting that PMEPA1 is a direct target of TGF-β signaling. Wild-type PMEPA1 and an alternative splice variant lacking the putative transmembrane domain were encoded by the PMEPA1 locus and were shown by epitope tagging to encode proteins with differing subcellular localization. Both variants were found to be expressed in normal colonic epithelium, and both were shown to be induced by TGF-β. Consistent with TGF-β playing a role in terminal differentiation of colonocytes, in situ hybridization of normal colonic epithelium localized PMEPA1 expression to nonproliferating, terminally differentiated epithelium located at the top of colonic crypts. Intriguingly, in situ hybridization and Northern blot analysis showed that the expression of PMEPA1 was well maintained both in colon cancer primary tumors and in colon cancer liver metastases. PMEPA1 is thus a novel TGF-β-induced marker of a differentiated crypt cell population. Moreover, as PMEPA1 expression is maintained, presumptively in a TGF-β-independent manner after malignant transformation and metastasis, it demonstrates that even late colon cancers retain a strong capacity to execute many steps of the normal colonic differentiation program.

AB - To identify potential effectors of transforming growth factor (TGF)-β-mediated suppression of colon cancer, we used GeneChip® expression microarrays to identify TGF-β-induced genes in VACO 330, a nontransformed TGF-β-sensitive cell line derived from a human adenomatous colon polyp. PMEPA1 was identified as a gene highly up-regulated by TGF-β treatment of VACO 330. Northern blot analysis confirmed TGF-β induction of PMEPA1 in VACO 330, as well as a panel of three other TGF-β-sensitive colon cell lines. PMEPA1 induction could be detected as early as 2 h after TGF-β treatment and was not inhibited by pretreatment of cells with cycloheximide, suggesting that PMEPA1 is a direct target of TGF-β signaling. Wild-type PMEPA1 and an alternative splice variant lacking the putative transmembrane domain were encoded by the PMEPA1 locus and were shown by epitope tagging to encode proteins with differing subcellular localization. Both variants were found to be expressed in normal colonic epithelium, and both were shown to be induced by TGF-β. Consistent with TGF-β playing a role in terminal differentiation of colonocytes, in situ hybridization of normal colonic epithelium localized PMEPA1 expression to nonproliferating, terminally differentiated epithelium located at the top of colonic crypts. Intriguingly, in situ hybridization and Northern blot analysis showed that the expression of PMEPA1 was well maintained both in colon cancer primary tumors and in colon cancer liver metastases. PMEPA1 is thus a novel TGF-β-induced marker of a differentiated crypt cell population. Moreover, as PMEPA1 expression is maintained, presumptively in a TGF-β-independent manner after malignant transformation and metastasis, it demonstrates that even late colon cancers retain a strong capacity to execute many steps of the normal colonic differentiation program.

UR - http://www.scopus.com/inward/record.url?scp=0037380885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037380885&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 1568

EP - 1575

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -